Shanghai Leadingtac Pharmaceutical Co., Ltd.

Chine

 
Quantité totale PI 13
Rang # Quantité totale PI 118 686
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 394

Brevets

Marques

0 0
0 0
13 0
0
 
Dernier brevet 2024 - Irak4 degradation agent and use ...
Premier brevet 2021 - Indazole derivative, and prepara...

Derniers inventions, produits et services

2023 Invention Irak4 degradation agent and use thereof. The present invention relates to use of compounds of for...
Invention Benzyl or thienylmethylene-substituted aminoquinazoline derivative and use thereof as sos1 degrad...
Invention Pan-kras degrading agent, and preparation method therefor and use thereof. Provided in the presen...
Invention Kras g12d degradation agent, and preparation method and use therefor. Disclosed in the present in...
Invention Sos1 protein degradation agent and use thereof. Provided in the present invention are an SOS1 pro...
2022 Invention Irak4 degradation agent, and preparation method therefor and use thereof. An IRAK4 degradation ag...
Invention Sos1 degrader, preparation method therefor and application thereof. An SOS1 degrader, a preparati...
Invention Sos1 degrading agent and preparation method therefor and application thereof. An SOS1 degrading a...
Invention Sos1 degradation agent and preparation method therefor and application thereof. An SOS1 degradati...
2021 Invention Coagulation factor xia inhibitor, preparation method therefor and use thereof. Provided are a coa...
Invention Compound for targeting and degrading protein, and preparation method therefor and use thereof. Pr...
Invention Use of irak4 inhibitor in treatment of acute lung injury ali/ards. A use of an IRAK4 small-molecu...
Invention Indazole derivative, and preparation method therefor and use thereof. Provided are a class of ind...